2021-12-19-世界卫生组织-COVID-19_Virtual_Press_conference_transcript_-_20_December_2021_41页_252kb

Coronavirus Disease 2019 (COVID-19)

Virtual Press Conference
20 December 2021

Session Overview:

This comprehensive press conference took place on December 20, 2021, at the World Health Organization (WHO) headquarters in Geneva. Key speakers included Dr. Tedros Adhanom Ghebreyesus (WHO Director-General), Dr. Soumya Swaminathan (WHO Chief Scientist), Dr. Michael Ryan (WHO Assistant Director-General for Crisis Response), and representatives from various countries and organizations. The discussion centered on the Omicron variant, the effectiveness of vaccines against it, global vaccination equity, public health measures, and the overall trajectory of the pandemic.

Key Points Discussed:

Omicron Variant Dominance:

• The WHO Director-General stated that the Omicron variant is spreading significantly faster than Delta and poses the highest transmissibility to date.
• Cases had increased dramatically, even surpassing Africa's infection rates from the previous week.
• Omicron appears to evade immunity more effectively, leading to concerns about breakthrough infections and reinfections.

Vaccination Progress and Equity Issues:

• Despite efforts to achieve widespread vaccination globally, nearly 50% of the world's population remained unvaccinated.
• WHO emphasized the need to prioritize vaccinating the unvaccinated to end the acute phase of the pandemic, rather than rushing booster shots.
• Challenges in production and distribution capacities, especially in low-income countries, were highlighted as major obstacles to vaccine equity.

Omicron and Vaccine Effectiveness:

• While Omicron reduces vaccine-induced neutralizing antibodies, early evidence indicates that vaccines still provide significant protection against severe disease, particularly in vulnerable populations.
• Boosters are recommended for those at high risk, but primary vaccination coverage is a priority.
• Scientists are urgently working on improving vaccines and antivirals, with trials ongoing for treatments such as Paxlovid and Molnupiravir.

End of the Pandemic:

• WHO outlined a pathway to ending the pandemic by ensuring equitable access to vaccines and treatments, accelerating the "endemic phase" of COVID-19.
• The Director-General declared 2022 as a "year of action" and encouraged member states to work together to achieve pandemic control.

Long-Term Challenges:

• Beyond COVID-19, WHO officials discussed setbacks in progress on other health issues such as malaria, maternal health, and childhood nutrition due to pandemic disruptions.
• The organization reiterated the importance of maintaining health systems and coordinating efforts to address global health goals like the Sustainable Development Goals (SDGs) and Universal Health Coverage (UHC).

Advisory Notes:

• Public Health Measures: WHO stressed the importance of continuing physical distancing, mask-wearing, good ventilation, and hand hygiene as tools to contain transmission.
• New Treatments: WHO stated that recommendations for COVID treatments would be issued in the coming weeks, based on ongoing clinical trials and expert assessments.
• Inequity Concerns: Calls to maintain solidarity through vaccine distribution and avoid racial inequities in medical research and funding were reiterated.

Conclusion:

The press conference concluded with an optimistic outlook for ending the pandemic in 2022, but emphasized the urgency to act swiftly with solidarity in international cooperation. WHO’s goals for 2022 include strengthening global health systems, advancing research on new COVID-19 tools, addressing vaccine equity, and preparing for the virus' long-term integration into global health dynamics.